No abstract available.
Transanal Endoscopic Microsurgery*

Transanal endoscopic microsurgery is considered a safe, appropriate, and minimally invasive approach, and complications after endoscopic microsurgery are rare. We report a case of sepsis and pneumoretroperitoneum after resection of a rectal lateral spreading tumor. The patient presented with rectal mucous discharge. Colonoscopy revealed a rectal lateral spreading tumor. The patient underwent an endoscopic transanal resection of the lesion. He presented with sepsis of the abdominal focus, and imaging tests revealed pneumoretroperitoneum. A new surgical intervention was performed with a loop colostomy. Despite the existence of other reports on pneumoretroperitoneum after transanal endoscopic microsurgery, what draws attention to this case is the association with sepsis.
Colonoscopy ; Colostomy ; Humans ; Microsurgery ; Retropneumoperitoneum* ; Sepsis* ; Transanal Endoscopic Microsurgery

Transanal endoscopic microsurgery(TEM) is a safe and effective procedure for the treatment of local tumors, especially for the rectal villous adenoma (pT0), polyps with severe dysplasia and in situ carcinoma(pTis). It can also be applied as salvage surgery for incidental carcinoma after colonoscopy as well as in cases of giant villous adenoma. With the introduction of screening colonoscopy, more early polyps will be detected. We should be able to customize our treatment accordingly. On one hand, we want to prevent overkill and on the other hand to avoid under-treatment. This article is aimed to review the development of TEM and discuss its various indications.
Carcinoma in Situ ; Colonoscopy ; Humans ; Polyps ; Rectal Neoplasms ; Transanal Endoscopic Microsurgery

The development of transanal endoscopic microsurgery (TEM) during the last 30 years has led to the evolution of the treatment in rectal neoplasms. TEM has revolutionized the technique and outcomes of transanal surgery. To our knowledge, this technique is currently the only one-port system in endoscopic surgery by which a direct endoluminal approach to the target organ by using a natural opening of the body become available. TEM affords the advantage of a less invasive transanal approach with low recurrence rates secondary to a more precise dissection due to enhanced visualization of the surgical field. Currently, TEM represents the standard treatment modality for large rectal adenomas and a surgical option in selected early rectal cancers. Its potential role in the treatment of more invasive cancer in combination with neoadjuvant therapies, and other rectal localized tumors are currently under evaluation. The current trend of TEM is favorable in China. TEM has also been increasingly used in the treatment of rectal neoplasms, but there are many problems in the development of TEM, for example, preoperative assessment is inadequate, patient selection is not precise enough, the surgical procedure is not standardized, etc. These problems require the majority of surgical colleagues to work together to make the standards scientifically and objectively in accordance with the actual situation of our country, so as to promote the healthy development and popularity of TEM in China.
Adenoma ; China ; Humans ; Neoadjuvant Therapy ; Patient Selection ; Rectal Neoplasms ; Transanal Endoscopic Microsurgery

OBJECTIVETo explore the accuracy of endoscopic ultrasound (EUS) in preoperative staging of rectal cancer and to guide the treatment of transanal endoscopic microsurgery (TEM) in early rectal cancer.

METHODSClinical data of 80 patients with rectal cancer receiving EUS examination for preoperative staging in our department between June and December 2012 were retrospectively analyzed. Consistence comparison of EUS preoperative staging and pathological staging was performed to identify the accuracy of EUS preoperative staging. All the patients underwent operation within 1 week after EUS examination. According to preoperative staging, early rectal cancer(Tis or T1N0M0) patients with lesions less 20 cm to anus underwent TEM.

RESULTSThe overall accuracy of EUS for preoperative T stage was 68.8%(55/80), and for T1, T2, T3, T4 was 91.3%(73/80), 83.8%(68/80), 77.5%(62/80), 85.0%(67/80), which had a good consistence with postoperative pathological T staging(Kappa=0.562). The overall accuracy of EUS for preoperative N stage was 52.7%(39/74), and for N0, N1, N2 stage was 64.9%(48/74), 55.4%(41/74), 85.1%(63/74), which had a poor consistence with postoperative pathological N staging(Kappa=0.235). Six patients underwent TEM successfully, with mean operation time 99(65 to 123) min, without intraoperative and postoperative complication, and were discharged 2-3 days after operation. Enteroscope showed good recovery 1 month later. Pathology confirmed that all the lesions were early rectal cancer. During postoperative follow-up of 14.8 (11 to 19) months, there was no local recurrence and distant metastasis.

CONCLUSIONPreoperative EUS has a good accuracy with pathologic T stage, and can guide TEM in early rectal cancer.

Anal Canal ; Endosonography ; Humans ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Postoperative Complications ; Rectal Neoplasms ; Retrospective Studies ; Transanal Endoscopic Microsurgery

OBJECTIVETo investigate the safety and feasibility of transanal endoscopic microsurgery combined with laparoscopic total mesorectal resection for lower rectal cancer.

METHODClinical data of seventeen patients with low rectal cancer undergoing the transanal endoscopic microsurgery combined with laparoscopic total mesorectal resection in our department from November 2014 to June 2015 were retrospectively analyzed. The main outcome measures included the operative time, intra-operative blood loss, the intra- and post-operative complication rate, the distal resection margin (DRM) length and the circumferential resection margin(CRM) status of the pathological specimen, as well as the number of lymph nodes retried.

RESULTSThe surgery was completed smoothly for all the patients in this studying group, with no conversion to open surgery. Among all the seventeen patients, seven had a body mass index (BMI) of over 25. The average operative time was (178.0 ± 32.3) min. The average intra-operative blood loss was (50.6 ± 43.98) ml. The complications included one case of intra-operative presacral venous hemorrhage(5.9%), and 3 cases of post-operative anastomotic leak (17.6%). The average distance from the distal resection margin to the lower edge of the tumor was (2.2 ± 1.6) cm. The distal, proximal, and circumferential resection margins were all negative in 17 patients. The average number of lymph nodes retrieved was 14.5 ± 6.9. The average postoperative hospital stay was (10.6 ± 6.7) d. Patients were followed up for an average period of (7.0 ± 2.6) months.

CONCLUSIONTransanal endoscopic microsurgery combined with laparoscopic total mesorectal resection in the treatment of lower rectal cancer is technically safe and feasible.

Anastomotic Leak ; Blood Loss, Surgical ; Colonoscopy ; Feasibility Studies ; Humans ; Laparoscopy ; Length of Stay ; Operative Time ; Postoperative Complications ; Rectal Neoplasms ; Retrospective Studies ; Transanal Endoscopic Microsurgery

PURPOSE: The purpose of this study was to look at our complication rates and recurrence rates, as well as the need for further radical surgery, in treating patients with benign and early malignant rectal tumors by using transanal endoscopic microsurgery (TEM). METHODS: Our study included 130 patients who had undergone TEM for rectal adenomas and early rectal cancer from December 2009 to December 2015 at the Department of Surgical Oncology, National Cancer Institute, Lithuania. Patients underwent digital and endoscopic evaluation with multiple biopsies. For preoperative staging, pelvic magnetic resonance imaging or endorectal ultrasound was performed. We recorded the demographics, operative details, final pathologies, postoperative lengths of hospital stay, postoperative complications, and recurrences. RESULTS: The average tumor size was 2.8 ± 1.5 cm (range, 0.5–8.3 cm). 102 benign (78.5%) and 28 malignant tumors (21.5%) were removed. Of the latter, 23 (82.1%) were pT1 cancers and 5 (17.9%) pT2 cancers. Of the 5 patients with pT2 cancer, 2 underwent adjuvant chemoradiotherapy, 1 underwent an abdominoperineal resection, 1 refused further treatment and 1 was lost to follow up. No intraoperative complications occurred. In 7 patients (5.4%), postoperative complications were observed: urinary retention (4 patients, 3.1%), postoperative hemorrhage (2 patients, 1.5%), and wound dehiscence (1 patient, 0.8%). All complications were treated conservatively. The mean postoperative hospital stay was 2.3 days. CONCLUSION: TEM in our experience demonstrated low complication and recurrence rates. This technique is recommended for treating patients with a rectal adenoma and early rectal cancer and has good prognosis.
Adenoma ; Biopsy ; Chemoradiotherapy, Adjuvant ; Demography ; Humans ; Intraoperative Complications ; Length of Stay ; Lithuania ; Lost to Follow-Up ; Magnetic Resonance Imaging ; National Cancer Institute (U.S.) ; Pathology ; Postoperative Complications ; Postoperative Hemorrhage ; Prognosis ; Rectal Neoplasms* ; Recurrence ; Transanal Endoscopic Microsurgery* ; Ultrasonography ; Urinary Retention ; Wounds and Injuries

OBJECTIVE: To investigate the efficacy of transanal endoscopic microsurgery (TEM) combined with imatinib for rectal gastrointestinal stromal tumors(GIST). METHODS: Clinical data of 35 patients with rectal GIST undergoing TEM at Peking Union Medical College Hospital from February 2008 to May 2017 were analyzed retrospectively. Operation details, postoperative recovery condition, and follow-up information were reviewed. The differences in clinicopathological features and perioperative parameters were compared between patients who received neoadjuvant therapy (12 patients, imatinib mesylate, oral, 400 mg daily for 6 months before surgery) and those without neoadjuvant therapy (23 patients). RESULTS: Of 35 patients, 18 were males and 17 were females with the mean age of (49.3±13.3) years. Mean tumor diameter was (1.8±1.1) cm and mean distance from lower tumor margin to anal verge was (4.0±1.8) cm. Mean operative time was (82.4±21.1) minutes and mean blood loss was (11.7±7.5) ml. No conversion to laparotomy occurred. Complete resection with negative margins was achieved in all cases. Complications were classified according to Clavien-Dindo system: 4 cases of grade I, 3 of grade II and 1 of grade IIIb. The tumor size in patients who received neoadjuvant therapy reduced from (3.1±1.2) cm to (2.6±1.2) cm, though it was still larger than the tumor size in patients without neoadjuvant therapy[(1.5±0.8) cm, P<0.01]. No significant difference in operative time was found between patients with and without neoadjuvant therapy [(76.7±24.8) minutes vs. (85.4±18.8) minutes, P>0.05]. Thirty patients (85.7%) were followed up for (50.3±36.6) months, and no local recurrence or metastasis was observed. CONCLUSIONS TEM is safe and effective in the treatment of rectal GIST. Preoperative neoadjuvant therapy is beneficial to TEM in treating larger tumors without increasing operating time. Satisfactory follow-up result is observed.
Adult ; Female ; Gastrointestinal Stromal Tumors ; drug therapy ; surgery ; Humans ; Imatinib Mesylate ; therapeutic use ; Male ; Middle Aged ; Rectal Neoplasms ; drug therapy ; surgery ; Retrospective Studies ; Transanal Endoscopic Microsurgery ; standards ; Treatment Outcome